Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hannah L. Golden is active.

Publication


Featured researches published by Hannah L. Golden.


Nature Reviews Neurology | 2012

The paradox of syndromic diversity in Alzheimer disease.

Jason D. Warren; Phillip D. Fletcher; Hannah L. Golden

Variant syndromes of Alzheimer disease (AD), led by deficits that extend beyond memory dysfunction, are of considerable clinical and neurobiological importance. Such syndromes present major challenges for both diagnosis and monitoring of disease, and serve to illustrate the apparent paradox of a clinically diverse group of disorders underpinned by a common histopathological substrate. This Review focuses on the most common variant AD phenotypes: posterior cortical atrophy, logopenic variant primary progressive aphasia and frontal variant AD. The neuroanatomical, molecular and pathological correlates of these phenotypes are highlighted, and the heterogeneous clinical presentations of the syndromes are discussed in the context of the emerging network paradigm of neurodegenerative disease. We argue that these apparently diverse clinical phenotypes reflect the differential involvement of a common core temporoparietofrontal network that is vulnerable to AD. According to this interpretation, the network signatures corresponding to AD variant syndromes are produced by genetic and other modulating factors that have yet to be fully characterized. The clinical and neurobiological implications of this network paradigm in the quest for disease-modifying treatments are also explored.


Neurobiology of Aging | 2013

White matter tract signatures of the progressive aphasias.

Colin J. Mahoney; Ian B. Malone; Gerard R. Ridgway; Aisling H. Buckley; Laura E. Downey; Hannah L. Golden; Natalie S. Ryan; Sebastien Ourselin; Jonathan M. Schott; Nick C. Fox; Jason D. Warren

The primary progressive aphasias (PPA) are a heterogeneous group of language-led neurodegenerative diseases resulting from large-scale brain network degeneration. White matter (WM) pathways bind networks together, and might therefore hold information about PPA pathogenesis. Here we used diffusion tensor imaging and tract-based spatial statistics to compare WM tract changes between PPA syndromes and with respect to Alzheimers disease and healthy controls in 33 patients with PPA (13 nonfluent/agrammatic PPA); 10 logopenic variant PPA; and 10 semantic variant PPA. Nonfluent/agrammatic PPA was associated with predominantly left-sided and anterior tract alterations including uncinate fasciculus (UF) and subcortical projections; semantic variant PPA with bilateral alterations in inferior longitudinal fasciculus and UF; and logopenic variant PPA with bilateral but predominantly left-sided alterations in inferior longitudinal fasciculus, UF, superior longitudinal fasciculus, and subcortical projections. Tract alterations were more extensive than gray matter alterations, and the extent of alteration across tracts and PPA syndromes varied between diffusivity metrics. These WM signatures of PPA syndromes illustrate the selective vulnerability of brain language networks in these diseases and might have some pathologic specificity.


Alzheimer's Research & Therapy | 2012

Longitudinal neuroimaging and neuropsychological profiles of frontotemporal dementia with C9ORF72 expansions

Colin J. Mahoney; Laura E. Downey; Gerard R. Ridgway; Jon Beck; Shona Clegg; Melanie Blair; Sarah Finnegan; Kelvin K. Leung; Tom Yeatman; Hannah L. Golden; Simon Mead; Jonathan D. Rohrer; Nick C. Fox; Jason D. Warren

IntroductionFrontotemporal dementia (FTD) is a common cause of early-onset dementia with a significant genetic component, as underlined by the recent identification of repeat expansions in the gene C9ORF72 as a major cause of FTD and motor neuron disease. Understanding the neurobiology and clinical phenomenology of this novel mutation is currently a major research focus. However, few data are available concerning the longitudinal evolution of this genetic disease. Here we present longitudinal neuropsychological and neuroimaging data on a cohort of patients with pathological repeat expansions in C9ORF72.MethodsFollowing a review of the University College London FTD DNA database, 20 cases were retrospectively identified with a C9ORF72 expansion. Twelve cases had longitudinal neuropsychology data available and six of these cases also had longitudinal volumetric brain magnetic resonance imaging. Cortical and subcortical volumes were extracted using FreeSurfer. Rates of whole brain, hemispheric, cerebellar and ventricular change were calculated for each subject. Nonlinear fluid registration of follow-up to baseline scan was performed to visualise longitudinal intra-subject patterns of brain atrophy and ventricular expansion.ResultsPatients had low average verbal and performance IQ at baseline that became impaired (< 5th percentile) at follow-up. In particular, visual memory, naming and dominant parietal skills all showed deterioration. Mean rates of whole brain atrophy (1.4%/year) and ventricular expansion (3.2 ml/year) were substantially greater in patients with the C9ORF72 mutation than in healthy controls; atrophy was symmetrical between the cerebral hemispheres within the C9ORF72 mutation group. The thalamus and cerebellum showed significant atrophy whereas no cortical areas were preferentially affected. Longitudinal fluid imaging in individual patients demonstrated heterogeneous patterns of progressive volume loss; however, ventricular expansion and cerebellar volume loss were consistent findings.ConclusionDisease evolution in C9ORF72-associated FTD is linked neuropsychologically with increasing involvement of parietal and amnestic functions, and neuroanatomically with rather diffuse and variable cortical and central atrophy but more consistent involvement of the cerebellum and thalamus. These longitudinal profiles are consistent with disease spread within a distributed subcortical network and demonstrate the feasibility of longitudinal biomarkers for tracking the evolution of the C9ORF72 mutation phenotype.


Human Brain Mapping | 2014

Profiles of White Matter Tract Pathology in Frontotemporal Dementia

Colin J. Mahoney; Gerard R. Ridgway; Ian B. Malone; Laura E. Downey; Jonathan Beck; Kirsi M. Kinnunen; Nicole Schmitz; Hannah L. Golden; Jonathan D. Rohrer; Jonathan M. Schott; Sebastien Ourselin; Simon Mead; Nick C. Fox; Jason D. Warren

Despite considerable interest in improving clinical and neurobiological characterisation of frontotemporal dementia and in defining the role of brain network disintegration in its pathogenesis, information about white matter pathway alterations in frontotemporal dementia remains limited. Here we investigated white matter tract damage using an unbiased, template‐based diffusion tensor imaging (DTI) protocol in a cohort of 27 patients with the behavioral variant of frontotemporal dementia (bvFTD) representing both major genetic and sporadic forms, in relation both to healthy individuals and to patients with Alzheimers disease. Widespread white matter tract pathology was identified in the bvFTD group compared with both healthy controls and Alzheimers disease group, with prominent involvement of uncinate fasciculus, cingulum bundle and corpus callosum. Relatively discrete and distinctive white matter profiles were associated with genetic subgroups of bvFTD associated with MAPT and C9ORF72 mutations. Comparing diffusivity metrics, optimal overall separation of the bvFTD group from the healthy control group was signalled using radial diffusivity, whereas optimal overall separation of the bvFTD group from the Alzheimers disease group was signalled using fractional anisotropy. Comparing white matter changes with regional grey matter atrophy (delineated using voxel based morphometry) in the bvFTD cohort revealed co‐localisation between modalities particularly in the anterior temporal lobe, however white matter changes extended widely beyond the zones of grey matter atrophy. Our findings demonstrate a distributed signature of white matter alterations that is likely to be core to the pathophysiology of bvFTD and further suggest that this signature is modulated by underlying molecular pathologies. Hum Brain Mapp 35:4163–4179, 2014.


Brain | 2015

Pain and temperature processing in dementia: a clinical and neuroanatomical analysis

Phillip D. Fletcher; Laura E. Downey; Hannah L. Golden; Camilla N. Clark; Catherine F. Slattery; Ross W. Paterson; Jonathan D. Rohrer; Jonathan M. Schott; Jason D. Warren

Symptoms suggesting altered pain and temperature processing have been described in dementia diseases. Using a semi-structured caregiver questionnaire and MRI voxel-based morphometry in patients with frontotemporal degeneration or Alzheimer’s disease, Fletcher et al. show that these symptoms are underpinned by atrophy in a distributed thalamo-temporo-insular network implicated in somatosensory processing.


Journal of Neurology | 2016

Hearing and dementia.

Chris J.D. Hardy; Charles R. Marshall; Hannah L. Golden; Camilla N. Clark; Catherine J. Mummery; Timothy D. Griffiths; Doris-Eva Bamiou; Jason D. Warren

Hearing deficits associated with cognitive impairment have attracted much recent interest, motivated by emerging evidence that impaired hearing is a risk factor for cognitive decline. However, dementia and hearing impairment present immense challenges in their own right, and their intersection in the auditory brain remains poorly understood and difficult to assess. Here, we outline a clinically oriented, symptom-based approach to the assessment of hearing in dementias, informed by recent progress in the clinical auditory neuroscience of these diseases. We consider the significance and interpretation of hearing loss and symptoms that point to a disorder of auditory cognition in patients with dementia. We identify key auditory characteristics of some important dementias and conclude with a bedside approach to assessing and managing auditory dysfunction in dementia.


Annals of Neurology | 2015

Longitudinal diffusion tensor imaging in frontotemporal dementia.

Colin J. Mahoney; Ivor J. A. Simpson; Jennifer M. Nicholas; Phillip D. Fletcher; Laura E. Downey; Hannah L. Golden; Camilla N. Clark; Nicole Schmitz; Jonathan D. Rohrer; Jonathan M. Schott; Hui Zhang; Sebastian Ourselin; Jason D. Warren; Nick C. Fox

Novel biomarkers for monitoring progression in neurodegenerative conditions are needed. Measurement of microstructural changes in white matter (WM) using diffusion tensor imaging (DTI) may be a useful outcome measure. Here we report trajectories of WM change using serial DTI in a cohort with behavioral variant frontotemporal dementia (bvFTD).


NeuroImage: Clinical | 2015

White matter tract signatures of impaired social cognition in frontotemporal lobar degeneration

Laura E. Downey; Colin J. Mahoney; Aisling H. Buckley; Hannah L. Golden; Susie M.D. Henley; Nicole Schmitz; Jonathan M. Schott; Ivor J. A. Simpson; Sebastien Ourselin; Nick C. Fox; Sebastian J. Crutch; Jason D. Warren

Impairments of social cognition are often leading features in frontotemporal lobar degeneration (FTLD) and likely to reflect large-scale brain network disintegration. However, the neuroanatomical basis of impaired social cognition in FTLD and the role of white matter connections have not been defined. Here we assessed social cognition in a cohort of patients representing two core syndromes of FTLD, behavioural variant frontotemporal dementia (bvFTD; n = 29) and semantic variant primary progressive aphasia (svPPA; n = 15), relative to healthy older individuals (n = 37) using two components of the Awareness of Social Inference Test, canonical emotion identification and sarcasm identification. Diffusion tensor imaging (DTI) was used to derive white matter tract correlates of social cognition performance and compared with the distribution of grey matter atrophy on voxel-based morphometry. The bvFTD and svPPA groups showed comparably severe deficits for identification of canonical emotions and sarcasm, and these deficits were correlated with distributed and overlapping white matter tract alterations particularly affecting frontotemporal connections in the right cerebral hemisphere. The most robust DTI associations were identified in white matter tracts linking cognitive and evaluative processing with emotional responses: anterior thalamic radiation, fornix (emotion identification) and uncinate fasciculus (sarcasm identification). DTI associations of impaired social cognition were more consistent than corresponding grey matter associations. These findings delineate a brain network substrate for the social impairment that characterises FTLD syndromes. The findings further suggest that DTI can generate sensitive and functionally relevant indexes of white matter damage in FTLD, with potential to transcend conventional syndrome boundaries.


Brain | 2015

Auditory spatial processing in Alzheimer’s disease

Hannah L. Golden; Jennifer M. Nicholas; Keir Yong; Laura E. Downey; Jonathan M. Schott; Catherine J. Mummery; Sebastian J. Crutch; Jason D. Warren

Auditory spatial processing is vulnerable in dementia. Golden et al. show that patients with typical Alzheimer’s disease or posterior cortical atrophy are impaired relative to controls in detecting the movement and location of sounds. The deficits have anatomical correlates in right parietal cortex, with implications for studies of network degeneration.


Journal of Neurology, Neurosurgery, and Psychiatry | 2014

Altered body schema processing in frontotemporal dementia with C9ORF72 mutations

Laura E. Downey; Phillip D. Fletcher; Hannah L. Golden; Colin J. Mahoney; Jennifer L. Agustus; Jonathan M. Schott; Jonathan D. Rohrer; Jonathan Beck; Simon Mead; Sebastian J. Crutch; Jason D. Warren

Background Mutations in C9ORF72 are an important cause of frontotemporal dementia (FTD) and motor neuron disease. Accumulating evidence suggests that FTD associated with C9ORF72 mutations (C9ORF72-FTD) is distinguished clinically by early prominent neuropsychiatric features that might collectively reflect deranged body schema processing. However, the pathophysiology of C9ORF72-FTD has not been elucidated. Methods We undertook a detailed neurophysiological investigation of five patients with C9ORF72-FTD, in relation to patients with FTD occurring sporadically and on the basis of mutations in the microtubule-associated protein tau gene and healthy older individuals. We designed or adapted behavioural tasks systematically to assess aspects of somatosensory body schema processing (tactile discrimination, proprioceptive and body part illusions and self/non-self differentiation). Results Patients with C9ORF72-FTD selectively exhibited deficits at these levels of body schema processing in relation to healthy individuals and other patients with FTD. Conclusions Altered body schema processing is a novel, generic pathophysiological mechanism that may link the distributed cortico-subcortical network previously implicated in C9ORF72-FTD with a wide range of neuropsychiatric and behavioural symptoms, and constitute a physiological marker of this neurodegenerative proteinopathy.

Collaboration


Dive into the Hannah L. Golden's collaboration.

Top Co-Authors

Avatar

Jason D. Warren

UCL Institute of Neurology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Laura E. Downey

UCL Institute of Neurology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Camilla N. Clark

UCL Institute of Neurology

View shared research outputs
Top Co-Authors

Avatar

Catherine J. Mummery

Cognition and Brain Sciences Unit

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Colin J. Mahoney

UCL Institute of Neurology

View shared research outputs
Researchain Logo
Decentralizing Knowledge